Immunic | VTL - Ebitda

Stock Price
1.32
Daily Change
0.07 5.60%
Monthly
39.28%
Yearly
10.00%
Q1 Forecast
1.07

Immunic reported $-22.78M in EBITDA for its fiscal quarter ending in June of 2024.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
BioMarin Pharmaceutical USD -24.17M 18.91M Dec/2025
Cipla INR 12.55B 6.4B Dec/2025
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 3.13B 1.17B Dec/2025
Grifols EUR 482.04M 7.04M Sep/2025
Immunic USD -22.78M 753K Jun/2024
Insmed USD -314.19M 31.48M Dec/2025
Omeros USD -47.96M 7.39M Sep/2023
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quidel USD 153.3M 23.8M Dec/2025
Ultragenyx Pharmaceutical USD -156.79M 65.44M Sep/2025
United Therapeutics USD 379.5M 83.4M Dec/2025
Xoma USD 2.52M 7.98M Jun/2024